Quantinno Capital Management LP Increases Position in Surgery Partners, Inc. $SGRY

Quantinno Capital Management LP increased its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 435.0% in the 1st quarter, HoldingsChannel.com reports. The fund owned 82,520 shares of the company’s stock after buying an additional 67,095 shares during the period. Quantinno Capital Management LP’s holdings in Surgery Partners were worth $984,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. UBS Group AG boosted its position in Surgery Partners by 111.4% in the fourth quarter. UBS Group AG now owns 7,803,974 shares of the company’s stock worth $120,571,000 after purchasing an additional 4,113,052 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Surgery Partners by 7.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 5,296,411 shares of the company’s stock valued at $63,131,000 after purchasing an additional 389,831 shares during the period. Hsbc Holdings PLC increased its position in shares of Surgery Partners by 104.2% during the 4th quarter. Hsbc Holdings PLC now owns 1,931,577 shares of the company’s stock valued at $30,151,000 after purchasing an additional 985,748 shares during the last quarter. Clearline Capital LP purchased a new stake in shares of Surgery Partners during the 4th quarter valued at $3,088,000. Finally, AYAL Capital Advisors Ltd raised its stake in shares of Surgery Partners by 80.0% during the 4th quarter. AYAL Capital Advisors Ltd now owns 225,000 shares of the company’s stock worth $3,476,000 after purchasing an additional 100,000 shares during the period.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $18.00 price target on shares of Surgery Partners in a report on Tuesday, August 11th. Royal Bank Of Canada decreased their price objective on shares of Surgery Partners from $20.00 to $19.00 and set an “outperform” rating for the company in a report on Tuesday, August 11th. Zacks Research lowered shares of Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 10th. Jefferies Financial Group reiterated a “buy” rating and issued a $17.00 target price on shares of Surgery Partners in a research note on Wednesday, May 6th. Finally, Benchmark reissued a “buy” rating on shares of Surgery Partners in a research report on Tuesday, August 11th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $19.45.

Surgery Partners Stock Performance

Shares of SGRY opened at $15.03 on Monday. The business has a 50-day moving average of $15.60 and a 200 day moving average of $14.41. Surgery Partners, Inc. has a fifty-two week low of $11.41 and a fifty-two week high of $24.10. The firm has a market cap of $1.97 billion, a P/E ratio of -21.47, a price-to-earnings-growth ratio of 4.08 and a beta of 1.92. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.06 by $0.04. The business had revenue of $848.90 million for the quarter, compared to the consensus estimate of $830.03 million. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The company’s revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.17 earnings per share. As a group, research analysts forecast that Surgery Partners, Inc. will post 0.25 EPS for the current year.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.